Search Results 501-510 of 18080 for Parkinson's disease
Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson's disease. NPJ Parkinsons Dis. 2024 Jan 08; 10(1):13. View PubMed ...
Heart conditions. CoQ10 has been shown to improve symptoms of congestive heart failure. · Diabetes. · Parkinson's disease. · Statin-induced myopathy. · Migraines.
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
It can help alleviate the adverse effects of sleep deprivation. Caffeine intake also is associated with a reduced risk of Parkinson's disease, Alzheimer's ...
Read more about research in Parkinson's Disease and Movement Disorders Laboratory and in the Movement Neurophysiology Laboratory. Publications. See a list of ...
... and often fatal because they are discovered in the advanced stages of the disease. ... Study Finds Parkinson's Disease Medication Triggers Destructive Behavior ...
Deep-brain stimulation in Parkinson's disease. Dr. Ince is working to find neuro-biomarkers for closed-loop deep brain stimulation in movement disorders such as ...
Udall Center of Excellence in Parkinson's Disease Research, and the National Institute of Neurological Disorders and Stroke. She also receives support from ...
Deep brain stimulation, Movement disorder, Parkinson's disease, Essential tremor, Dystonia. Research. Mayo Clinic doctors trained in nervous system conditions ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.